# Comparison Of Reduced DAPT Followed by P2Y12 Inhibitor Monotherapy With Prasugrel vs stAndard Regimen in STEMI Patients

> **NCT05491200** · PHASE4 · RECRUITING · sponsor: **Research Maatschap Cardiologen Rotterdam Zuid** · enrollment: 1656 (estimated)

## Conditions studied

- ST Elevated Myocardial Infarction
- Dual Antiplatelet Therapy

## Interventions

- **DRUG:** Prasugrel based short DAPT
- **DRUG:** Prasugrel based standard DAPT
- **DEVICE:** OCT guided revascularization
- **DEVICE:** Angio guided revascularization

## Key facts

- **NCT ID:** NCT05491200
- **Lead sponsor:** Research Maatschap Cardiologen Rotterdam Zuid
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-07-22
- **Primary completion:** 2026-08-01
- **Final completion:** 2028-08-01
- **Target enrollment:** 1656 (ESTIMATED)
- **Last updated:** 2025-08-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05491200

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05491200, "Comparison Of Reduced DAPT Followed by P2Y12 Inhibitor Monotherapy With Prasugrel vs stAndard Regimen in STEMI Patients". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT05491200. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*